Myeloproliferative disorders include several different conditions that are characterized by excess production of blood cells ...

and then there was a change from MPD [myeloproliferative disorder] to MPN. So it's a neoplastic disease, clearly, and has ...

Veliparib ER is under clinical development by AbbVie and currently in Phase II for Myeloproliferative Disorders.

Managing a younger person with a myeloproliferative neoplasm (MPN) includes a lot of long-term considerations, including ...

The measurable residual disease (MRD ... including acute myeloid leukemia (AML), myelodysplastic syndromes and myeloproliferative neoplasms. The trial was led by Courtney DiNardo, M.D., professor ...

The patients had diagnoses of MDSs, MDS/myeloproliferative neoplasm overlap ... The 5-year cumulative incidence of disease progression was higher in long-term smokers than in nonsmokers and ...